Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide in Obese Kidney Transplant Recipients
NCT07423247Phase 4Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in obesity, sponsored by Shahid Beheshti University of Medical Sciences. Started Jan 2026; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07423247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07423247.